Facts O O O O
About O O O O
the O O O O
Current O O O O
Good O O O O
Manufacturing O O O O
Practices O O O O
(CGMP) O O O O
[Pharmaceutical O O O O
Quality](/drugs/development-approval-process-drugs/pharmaceutical-quality-resources) O O O O
affects O O O O
every O O O O
American. O O O O
The O O O O
Food O O O O
and O O O O
Drug O O O O
Administration O O O O
(FDA) O O O O
regulates O O O O
the O O O O
quality O O O O
of O O O O
pharmaceuticals O O O O
very O O O O
carefully. O O O O
The O O O O
main O O O O
regulatory O O O O
standard O O O O
for O O O O
ensuring O O O O
pharmaceutical O O O O
quality O O O O
is O O O O
the O O O O
Current O O O O
Good O O O O
Manufacturing O O O O
Practice O O O O
(CGMP) O O O O
regulations O O O O
for O O O O
human O O O O
pharmaceuticals. O O O O
Consumers O O O O
expect O O O O
that O O O O
each O O O O
batch O O O O
of O O O O
medicines O O O O
they O O O O
take O O O O
will O O O O
meet O O O O
quality O O O O
standards O O O O
so O O O O
that O O O O
they O O O O
will O O O O
be O O O O
safe O O O O
and O O O O
effective. O O O O
Most O O O O
people, O O O O
however, O O O O
are O O O O
not O O O O
aware O O O O
of O O O O
CGMP, O O O O
or O O O O
how O O O O
FDA O O O O
assures O O O O
that O O O O
drug O O O O
manufacturing O O O O
processes O O O O
meet O O O O
these O O O O
basic O O O O
objectives. O O O O
Recently, O O O O
FDA O O O O
has O O O O
announced O O O O
a O O O O
number O O O O
of O O O O
regulatory O O O O
actions O O O O
taken O O O O
against O O O O
drug O O O O
manufacturers O O O O
based O O O O
on O O O O
the O O O O
lack O O O O
of O O O O
CGMP. O O O O
This O O O O
paper O O O O
discusses O O O O
some O O O O
facts O O O O
that O O O O
may O O O O
be O O O O
helpful O O O O
in O O O O
understanding O O O O
how O O O O
CGMP O O O O
establishes O O O O
the O O O O
foundation O O O O
for O O O O
drug O O O O
product O O O O
quality. O O O O
What Reason 3 O O
is Reason 3 O O
CGMP? Reason 3 O O
CGMP Reason 3 O O
refers Reason 3 O O
to Reason 3 O O
the Reason 3 O O
Current Reason 3 O O
Good Reason 3 O O
Manufacturing Reason 3 O O
Practice Reason 3 O O
regulations Reason 3 O O
enforced Reason 3 O O
by Reason 3 O O
the Reason 3 O O
FDA. Reason 3 O O
CGMP Reason 3 O O
provides Reason 3 O O
for Reason 3 O O
systems Reason 3 O O
that Reason 3 O O
assure Reason 3 O O
proper Reason 3 O O
design, Reason 3 O O
monitoring, Reason 3 O O
and Reason 3 O O
control Reason 3 O O
of Reason 3 O O
manufacturing Reason 3 O O
processes Reason 3 O O
and Reason 3 O O
facilities. Reason 3 O O
Adherence Reason 3 O O
to Reason 3 O O
the Reason 3 O O
[CGMP Reason 3 O O
regulations](/drugs/manufacturing/current-good-manufacturing-practice-cgmp-regulations) Reason 3 O O
assures Reason 3 O O
the Reason 3 O O
identity, Reason 3 O O
strength, Reason 3 O O
quality, Reason 3 O O
and Reason 3 O O
purity Reason 3 O O
of Reason 3 O O
drug Reason 3 O O
products Reason 3 O O
by Reason 3 O O
requiring Reason 3 O O
that Reason 3 O O
manufacturers Reason 3 O O
of Reason 3 O O
medications Reason 3 O O
adequately Reason 3 O O
control Reason 3 O O
manufacturing Reason 3 O O
operations. Reason 3 O O
This Reason 3 O O
includes Reason 3 O O
establishing Reason 3 O O
strong Reason 3 O O
quality Reason 3 O O
management Reason 3 O O
systems, Reason 3 O O
obtaining Reason 3 O O
appropriate Reason 3 O O
quality Reason 3 O O
raw Reason 3 O O
materials, Reason 3 O O
establishing Reason 3 O O
robust Reason 3 O O
operating Reason 3 O O
procedures, Reason 3 O O
detecting Reason 3 O O
and Reason 3 O O
investigating Reason 3 O O
product Reason 3 O O
quality Reason 3 O O
deviations, Reason 3 O O
and Reason 3 O O
maintaining Reason 3 O O
reliable Reason 3 O O
testing Reason 3 O O
laboratories. Reason 3 O O
This Reason 3 O O
formal Reason 3 O O
system Reason 3 O O
of Reason 3 O O
controls Reason 3 O O
at Reason 3 O O
a Reason 3 O O
pharmaceutical Reason 3 O O
company, Reason 3 O O
if Reason 3 O O
adequately Reason 3 O O
put Reason 3 O O
into Reason 3 O O
practice, Reason 3 O O
helps Reason 3 O O
to Reason 3 O O
prevent Reason 3 O O
instances Reason 3 O O
of Reason 3 O O
contamination, Reason 3 O O
mix-ups, Reason 3 O O
deviations, Reason 3 O O
failures, Reason 3 O O
and Reason 3 O O
errors. Reason 3 O O
This Reason 3 O O
assures Reason 3 O O
that Reason 3 O O
drug Reason 3 O O
products Reason 3 O O
meet Reason 3 O O
their Reason 3 O O
quality Reason 3 O O
standards. Reason 3 O O
The Reason 3 O O
CGMP Reason 3 O O
requirements Reason 3 O O
were Reason 3 O O
established Reason 3 O O
to Reason 3 O O
be Reason 3 O O
flexible Reason 3 O O
in Reason 3 O O
order Reason 3 O O
to Reason 3 O O
allow Reason 3 O O
each Reason 3 O O
manufacturer Reason 3 O O
to Reason 3 O O
decide Reason 3 O O
individually Reason 3 O O
how Reason 3 O O
to Reason 3 O O
best Reason 3 O O
implement Reason 3 O O
the Reason 3 O O
necessary Reason 3 O O
controls Reason 3 O O
by Reason 3 O O
using Reason 3 O O
scientifically Reason 3 O O
sound Reason 3 O O
design, Reason 3 O O
processing Reason 3 O O
methods, Reason 3 O O
and Reason 3 O O
testing Reason 3 O O
procedures. Reason 3 O O
The Reason 3 O O
flexibility Reason 3 O O
in Reason 3 O O
these Reason 3 O O
regulations Reason 3 O O
allows Reason 3 O O
companies Reason 3 O O
to Reason 3 O O
use Reason 3 O O
modern Reason 3 O O
technologies Reason 3 O O
and Reason 3 O O
innovative Reason 3 O O
approaches Reason 3 O O
to Reason 3 O O
achieve Reason 3 O O
higher Reason 3 O O
quality Reason 3 O O
through Reason 3 O O
continual Reason 3 O O
improvement. Reason 3 O O
Accordingly, Reason 3 O O
the Reason 3 O O
"C" Reason 3 O O
in Reason 3 O O
CGMP Reason 3 O O
stands Reason 3 O O
for Reason 3 O O
"current," Reason 3 O O
requiring Reason 3 O O
companies Reason 3 O O
to Reason 3 O O
use Reason 3 O O
technologies Reason 3 O O
and Reason 3 O O
systems Reason 3 O O
that Reason 3 O O
are Reason 3 O O
up-to-date Reason 3 O O
in Reason 3 O O
order Reason 3 O O
to Reason 3 O O
comply Reason 3 O O
with Reason 3 O O
the Reason 3 O O
regulations. Reason 3 O O
Systems Reason 3 O O
and Reason 3 O O
equipment Reason 3 O O
that Reason 3 O O
may Reason 3 O O
have Reason 3 O O
been Reason 3 O O
"top-of-the-line" Reason 3 O O
to Reason 3 O O
prevent Reason 3 O O
contamination, Reason 3 O O
mix-ups, Reason 3 O O
and Reason 3 O O
errors Reason 3 O O
10 Reason 3 O O
or Reason 3 O O
20 Reason 3 O O
years Reason 3 O O
ago Reason 3 O O
may Reason 3 O O
be Reason 3 O O
less Reason 3 O O
than Reason 3 O O
adequate Reason 3 O O
by Reason 3 O O
today's Reason 3 O O
standards. Reason 3 O O
It Reason 3 O O
is Reason 3 O O
important Reason 3 O O
to Reason 3 O O
note Reason 3 O O
that Reason 3 O O
CGMP Reason 3 O O
regulations Reason 3 O O
for Reason 3 O O
drugs Reason 3 O O
contain Reason 3 O O
the Reason 3 O O
minimum Reason 3 O O
requirements. Reason 3 O O
Many Reason 3 O O
pharmaceutical Reason 3 O O
manufacturers Reason 3 O O
are Reason 3 O O
already Reason 3 O O
implementing Reason 3 O O
comprehensive, Reason 3 O O
modern Reason 3 O O
quality Reason 3 O O
systems Reason 3 O O
and Reason 3 O O
risk Reason 3 O O
management Reason 3 O O
approaches Reason 3 O O
that Reason 3 O O
exceed Reason 3 O O
these Reason 3 O O
minimum Reason 3 O O
standards. Reason 3 O O
Why O O O O
is O O O O
CGMP O O O O
so O O O O
important? O O O O
A O O O O
consumer O O O O
usually O O O O
cannot O O O O
detect O O O O
(through O O O O
smell, O O O O
touch, O O O O
or O O O O
sight) O O O O
that O O O O
a O O O O
drug O O O O
product O O O O
is O O O O
safe O O O O
or O O O O
if O O O O
it O O O O
will O O O O
work. O O O O
While O O O O
CGMP O O O O
requires O O O O
testing, O O O O
testing O O O O
alone O O O O
is O O O O
not O O O O
adequate O O O O
to O O O O
ensure O O O O
quality. O O O O
In O O O O
most O O O O
instances O O O O
testing O O O O
is O O O O
done O O O O
on O O O O
a O O O O
small O O O O
sample O O O O
of O O O O
a O O O O
batch O O O O
(for O O O O
example, O O O O
a O O O O
drug O O O O
manufacturer O O O O
may O O O O
test O O O O
100 O O O O
tablets O O O O
from O O O O
a O O O O
batch O O O O
that O O O O
contains O O O O
2 O O O O
million O O O O
tablets), O O O O
so O O O O
that O O O O
most O O O O
of O O O O
the O O O O
batch O O O O
can O O O O
be O O O O
used O O O O
for O O O O
patients O O O O
rather O O O O
than O O O O
destroyed O O O O
by O O O O
testing. O O O O
Therefore, O O O O
it O O O O
is O O O O
important O O O O
that O O O O
drugs O O O O
are O O O O
manufactured O O O O
under O O O O
conditions O O O O
and O O O O
practices O O O O
required O O O O
by O O O O
the O O O O
CGMP O O O O
regulations O O O O
to O O O O
assure O O O O
that O O O O
quality O O O O
is O O O O
built O O O O
into O O O O
the O O O O
design O O O O
and O O O O
manufacturing O O O O
process O O O O
at O O O O
every O O O O
step. O O O O
Facilities O O O O
that O O O O
are O O O O
in O O O O
good O O O O
condition, O O O O
equipment O O O O
that O O O O
is O O O O
properly O O O O
maintained O O O O
and O O O O
calibrated, O O O O
employees O O O O
who O O O O
are O O O O
qualified O O O O
and O O O O
fully O O O O
trained, O O O O
and O O O O
processes O O O O
that O O O O
are O O O O
reliable O O O O
and O O O O
reproducible, O O O O
are O O O O
a O O O O
few O O O O
examples O O O O
of O O O O
how O O O O
CGMP O O O O
requirements O O O O
help O O O O
to O O O O
assure O O O O
the O O O O
safety O O O O
and O O O O
efficacy O O O O
of O O O O
drug O O O O
products. O O O O
How Reason 3 O O
does Reason 3 O O
FDA Reason 3 O O
determine Reason 3 O O
if Reason 3 O O
a Reason 3 O O
company Reason 3 O O
is Reason 3 O O
complying Reason 3 O O
with Reason 3 O O
CGMP Reason 3 O O
regulations? Reason 3 O O
FDA Reason 3 O O
inspects Reason 3 O O
pharmaceutical Reason 3 O O
manufacturing Reason 3 O O
facilities Reason 3 O O
worldwide, Reason 3 O O
including Reason 3 O O
facilities Reason 3 O O
that Reason 3 O O
manufacture Reason 3 O O
active Reason 3 O O
ingredients Reason 3 O O
and Reason 3 O O
the Reason 3 O O
finished Reason 3 O O
product. Reason 3 O O
Inspections Reason 3 O O
follow Reason 3 O O
a Reason 3 O O
standard Reason 3 O O
approach Reason 3 O O
and Reason 3 O O
are Reason 3 O O
conducted Reason 3 O O
by Reason 3 O O
highly Reason 3 O O
trained Reason 3 O O
FDA Reason 3 O O
staff. Reason 3 O O
FDA Reason 3 O O
also Reason 3 O O
relies Reason 3 O O
upon Reason 3 O O
reports Reason 3 O O
of Reason 3 O O
potentially Reason 3 O O
defective Reason 3 O O
drug Reason 3 O O
products Reason 3 O O
from Reason 3 O O
the Reason 3 O O
public Reason 3 O O
and Reason 3 O O
the Reason 3 O O
industry. Reason 3 O O
FDA Reason 3 O O
will Reason 3 O O
often Reason 3 O O
use Reason 3 O O
these Reason 3 O O
reports Reason 3 O O
to Reason 3 O O
identify Reason 3 O O
sites Reason 3 O O
for Reason 3 O O
which Reason 3 O O
an Reason 3 O O
inspection Reason 3 O O
or Reason 3 O O
investigation Reason 3 O O
is Reason 3 O O
needed. Reason 3 O O
Most Reason 3 O O
companies Reason 3 O O
that Reason 3 O O
are Reason 3 O O
inspected Reason 3 O O
are Reason 3 O O
found Reason 3 O O
to Reason 3 O O
be Reason 3 O O
fully Reason 3 O O
compliant Reason 3 O O
with Reason 3 O O
the Reason 3 O O
CGMP Reason 3 O O
regulations. Reason 3 O O
If Reason 3 O O
a Reason 3 O O
manufacturer Reason 3 O O
is Reason 3 O O
not Reason 3 O O
following Reason 3 O O
CGMP, Reason 3 O O
are O O O O
drug O O O O
products O O O O
safe O O O O
for O O O O
use O O O O
If O O O O
a O O O O
company O O O O
is O O O O
not O O O O
complying O O O O
with O O O O
CGMP O O O O
regulations, O O O O
any O O O O
drug O O O O
it O O O O
makes O O O O
is O O O O
considered O O O O
"adulterated" O O O O
under O O O O
the O O O O
law. O O O O
This O O O O
kind O O O O
of O O O O
adulteration O O O O
means O O O O
that O O O O
the O O O O
drug O O O O
was O O O O
not O O O O
manufactured O O O O
under O O O O
conditions O O O O
that O O O O
comply O O O O
with O O O O
CGMP. O O O O
It O O O O
does O O O O
not O O O O
mean O O O O
that O O O O
there O O O O
is O O O O
necessarily O O O O
something O O O O
wrong O O O O
with O O O O
the O O O O
drug. O O O O
For O O O O
consumers O O O O
currently O O O O
taking O O O O
medicines O O O O
from O O O O
a O O O O
company O O O O
that O O O O
was O O O O
not O O O O
following O O O O
CGMP, O O O O
FDA O O O O
usually O O O O
advises O O O O
these O O O O
consumers O O O O
not O O O O
to O O O O
interrupt O O O O
their O O O O
drug O O O O
therapy, O O O O
which O O O O
could O O O O
have O O O O
serious O O O O
implications O O O O
for O O O O
their O O O O
health. O O O O
Consumers O O O O
should O O O O
seek O O O O
advice O O O O
from O O O O
their O O O O
health O O O O
care O O O O
professionals O O O O
before O O O O
stopping O O O O
or O O O O
changing O O O O
medications. O O O O
Regulatory O O O O
actions O O O O
against O O O O
companies O O O O
with O O O O
poor O O O O
CGMP O O O O
are O O O O
often O O O O
intended O O O O
to O O O O
prevent O O O O
the O O O O
possibility O O O O
of O O O O
unsafe O O O O
and/or O O O O
ineffective O O O O
drugs. O O O O
In O O O O
rare O O O O
cases, O O O O
FDA O O O O
regulatory O O O O
action O O O O
is O O O O
intended O O O O
to O O O O
stop O O O O
the O O O O
distribution O O O O
or O O O O
manufacturing O O O O
of O O O O
violative O O O O
product. O O O O
The O O O O
impact O O O O
of O O O O
CGMP O O O O
violations O O O O
depends O O O O
on O O O O
the O O O O
nature O O O O
of O O O O
those O O O O
violations O O O O
and O O O O
on O O O O
the O O O O
specific O O O O
drugs O O O O
involved. O O O O
A O O O O
drug O O O O
manufactured O O O O
in O O O O
violation O O O O
of O O O O
CGMP O O O O
may O O O O
still O O O O
meet O O O O
its O O O O
labeled O O O O
specifications, O O O O
and O O O O
the O O O O
risk O O O O
that O O O O
the O O O O
drug O O O O
is O O O O
unsafe O O O O
or O O O O
ineffective O O O O
could O O O O
be O O O O
minimal. O O O O
Thus, O O O O
FDA's O O O O
advice O O O O
will O O O O
be O O O O
specific O O O O
to O O O O
the O O O O
circumstances, O O O O
and O O O O
health O O O O
care O O O O
professionals O O O O
are O O O O
best O O O O
able O O O O
to O O O O
balance O O O O
risks O O O O
and O O O O
benefits O O O O
and O O O O
make O O O O
the O O O O
right O O O O
decision O O O O
for O O O O
their O O O O
patients. O O O O
What Reason 3 O O
can Reason 3 O O
FDA Reason 3 O O
do Reason 3 O O
to Reason 3 O O
protect Reason 3 O O
the Reason 3 O O
public Reason 3 O O
when Reason 3 O O
there Reason 3 O O
are Reason 3 O O
CGMP Reason 3 O O
violations? Reason 3 O O
If Reason 3 O O
the Reason 3 O O
failure Reason 3 O O
to Reason 3 O O
meet Reason 3 O O
CGMP Reason 3 O O
results Reason 3 O O
in Reason 3 O O
the Reason 3 O O
distribution Reason 3 O O
of Reason 3 O O
a Reason 3 O O
drug Reason 3 O O
that Reason 3 O O
does Reason 3 O O
not Reason 3 O O
offer Reason 3 O O
the Reason 3 O O
benefit Reason 3 O O
as Reason 3 O O
labeled Reason 3 O O
because, O O O O
for O O O O
example, O O O O
it O O O O
has O O O O
too O O O O
little O O O O
active O O O O
ingredient, O O O O
the O O O O
company O O O O
may O O O O
subsequently O O O O
recall O O O O
that O O O O
product. O O O O
This O O O O
protects O O O O
the O O O O
public O O O O
from O O O O
further O O O O
harm O O O O
by O O O O
removing O O O O
these O O O O
drugs O O O O
from O O O O
the O O O O
market. O O O O
While O O O O
FDA O O O O
cannot O O O O
force O O O O
a O O O O
company O O O O
to O O O O
recall O O O O
a O O O O
drug, O O O O
companies O O O O
usually O O O O
will O O O O
recall O O O O
voluntarily O O O O
or O O O O
at O O O O
FDA's O O O O
request. O O O O
If O O O O
a O O O O
company O O O O
refuses O O O O
to O O O O
recall O O O O
a O O O O
drug, O O O O
FDA O O O O
can O O O O
warn O O O O
the O O O O
public O O O O
and O O O O
can O O O O
seize O O O O
the O O O O
drug. O O O O
FDA O O O O
can O O O O
also O O O O
bring O O O O
a O O O O
seizure O O O O
or O O O O
injunction O O O O
case O O O O
in O O O O
court O O O O
to O O O O
address O O O O
CGMP O O O O
violations O O O O
even O O O O
where O O O O
there O O O O
is O O O O
no O O O O
direct O O O O
evidence O O O O
of O O O O
a O O O O
defect O O O O
affecting O O O O
the O O O O
drug's O O O O
performance. O O O O
When O O O O
FDA O O O O
brings O O O O
a O O O O
seizure O O O O
case, O O O O
the O O O O
agency O O O O
asks O O O O
the O O O O
court O O O O
for O O O O
an O O O O
order O O O O
that O O O O
allows O O O O
federal O O O O
officials O O O O
to O O O O
take O O O O
possession O O O O
of O O O O
"adulterated" O O O O
drugs. O O O O
When O O O O
FDA O O O O
brings O O O O
an O O O O
injunction O O O O
case, O O O O
FDA O O O O
asks O O O O
the O O O O
court O O O O
to O O O O
order O O O O
a O O O O
company O O O O
to O O O O
stop O O O O
violating O O O O
CGMP. O O O O
Both O O O O
seizure O O O O
and O O O O
injunction O O O O
cases O O O O
often O O O O
lead O O O O
to O O O O
court O O O O
orders O O O O
that O O O O
require O O O O
companies O O O O
to O O O O
take O O O O
many O O O O
steps O O O O
to O O O O
correct O O O O
CGMP O O O O
violations, O O O O
which O O O O
may O O O O
include O O O O
repairing O O O O
facilities O O O O
and O O O O
equipment, O O O O
improving O O O O
sanitation O O O O
and O O O O
cleanliness, O O O O
performing O O O O
additional O O O O
testing O O O O
to O O O O
verify O O O O
quality, O O O O
and O O O O
improving O O O O
employee O O O O
training. O O O O
FDA O O O O
can O O O O
also O O O O
bring O O O O
criminal O O O O
cases O O O O
because O O O O
of O O O O
CGMP O O O O
violations, O O O O
seeking O O O O
fines O O O O
and O O O O
jail O O O O
time. O O O O
How Reason 3 O O
would Reason 3 O O
a Reason 3 O O
new Reason 3 O O
drug Reason 3 O O
company Reason 3 O O
learn Reason 3 O O
about Reason 3 O O
CGMP Reason 3 O O
and Reason 3 O O
about Reason 3 O O
FDA's Reason 3 O O
expectations Reason 3 O O
on Reason 3 O O
complying Reason 3 O O
with Reason 3 O O
them? Reason 3 O O
FDA Reason 3 O O
publishes Reason 3 O O
regulations Reason 3 O O
and Reason 3 O O
guidance Reason 3 O O
documents Reason 3 O O
for Reason 3 O O
industry Reason 3 O O
in Reason 3 O O
the Reason 3 O O
Federal Reason 3 O O
Register. Reason 3 O O
This Reason 3 O O
is Reason 3 O O
how Reason 3 O O
the Reason 3 O O
federal Reason 3 O O
government Reason 3 O O
notifies Reason 3 O O
the Reason 3 O O
public Reason 3 O O
of Reason 3 O O
what Reason 3 O O
we Reason 3 O O
are Reason 3 O O
doing Reason 3 O O
and Reason 3 O O
why. Reason 3 O O
FDA's Reason 3 O O
website, Reason 3 O O
[www.fda.gov](http://www.fda.gov/) O O O O
also O O O O
contains O O O O
links O O O O
to O O O O
the O O O O
CGMP O O O O
regulations, O O O O
[guidance O O O O
documents](https://www.fda.gov/regulatory-information/search-fda-guidance-documents), O O O O
and O O O O
various O O O O
resources O O O O
to O O O O
help O O O O
drug O O O O
companies O O O O
comply O O O O
with O O O O
the O O O O
law. O O O O
FDA O O O O
also O O O O
conducts O O O O
extensive O O O O
public O O O O
outreach O O O O
through O O O O
presentations O O O O
at O O O O
national O O O O
and O O O O
international O O O O
meetings O O O O
and O O O O
conferences, O O O O
to O O O O
discuss O O O O
and O O O O
explain O O O O
the O O O O
CGMP O O O O
requirements O O O O
and O O O O
the O O O O
latest O O O O
policy O O O O
documents O O O O
